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abstract
 
L-type Ca
 
2
 
1
 
 channel (L-channel) activity of the skeletal muscle dihydropyridine receptor is markedly
enhanced by the skeletal muscle isoform of the ryanodine receptor (RyR1) (Nakai, J., R.T. Dirksen, H.T. Nguyen,
 
I.N. Pessah, K.G. Beam, and P.D. Allen. 1996. 
 
Nature. 
 
380:72–75.). However, the dependence of the biophysical
and pharmacological properties of skeletal L-current on RyR1 has yet to be fully elucidated. Thus, we have evalu-
ated the inﬂuence of RyR1 on the properties of macroscopic L-currents and intracellular charge movements in
cultured skeletal myotubes derived from normal and “RyR1-knockout” (dyspedic) mice. Compared with normal
myotubes, dyspedic myotubes exhibited a 40% reduction in the amount of maximal immobilization-resistant
 
charge movement (Q
 
max
 
, 7.5 
 
6
 
 0.8 and 4.5 
 
6
 
 0.4 nC/
 
m
 
F for normal and dyspedic myotubes, respectively) and an
approximately ﬁvefold reduction in the ratio of maximal L-channel conductance to charge movement (G
 
max
 
/
Q
 
max
 
). Thus, RyR1 enhances both the expression level and Ca
 
2
 
1
 
 conducting activity of the skeletal L-channel. For
both normal and dyspedic myotubes, the sum of two exponentials was required to ﬁt L-current activation and re-
sulted in extraction of the amplitudes (A
 
fast
 
 and A
 
slow
 
) and time constants (
 
t
 
slow
 
 and 
 
t
 
fast
 
) for each component of
the macroscopic current. In spite of a 
 
.
 
10-fold in difference current density, L-currents in normal and dyspedic
 
myotubes exhibited similar relative contributions of fast and slow components (at 
 
1
 
40 mV; A
 
fast
 
/[A
 
fast 
 
1 
 
A
 
slow
 
] 
 
z
 
0.25). However, both 
 
t
 
fast
 
 and 
 
t
 
slow
 
 were signiﬁcantly (
 
P
 
 
 
, 
 
0.02) faster for myotubes lacking the RyR1 protein (
 
t
 
fast
 
,
8.5 
 
6
 
 1.2 and 4.4 
 
6
 
 0.5 ms; 
 
t
 
slow
 
, 79.5 
 
6
 
 10.5 and 34.6 
 
6
 
 3.7 ms at 
 
1
 
40 mV for normal and dyspedic myotubes, re-
spectively). In both normal and dyspedic myotubes, (
 
2
 
) Bay K 8644 (5 
 
m
 
M) caused a hyperpolarizing shift (
 
z
 
10
mV) in the voltage dependence of channel activation and an 80% increase in peak L-current. However, the in-
crease in peak L-current correlated with moderate increases in both A
 
slow
 
 and A
 
fast
 
 in normal myotubes, but a large
increase in only A
 
fast
 
 in dyspedic myotubes. Equimolar substitution of Ba
 
2
 
1
 
 for extracellular Ca
 
2
 
1
 
 increased both
A
 
fast
 
 and A
 
slow 
 
in normal myotubes. The identical substitution in dyspedic myotubes failed to signiﬁcantly alter the
magnitude of either A
 
fast
 
 or A
 
slow
 
. These results demonstrate that RyR1 inﬂuences essential properties of skeletal
L-channels (expression level, activation kinetics, modulation by dihydropyridine agonist, and divalent conduc-
tance) and supports the notion that RyR1 acts as an important allosteric modulator of the skeletal L-channel, anal-
ogous to that of a Ca
 
2
 
1
 
 channel accessory subunit.
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INTRODUCTION
 
Skeletal and cardiac muscle dihydropyridine receptors
 
(DHPRs)
 
1
 
 are voltage-dependent L-type calcium chan-
nels (L-channels) (Tanabe et al., 1988; Mikami et al.,
 
1989) that control the activity of intracellular Ca
 
2
 
1
 
 re-
lease channels, ryanodine receptors (RyRs), during ex-
citation–contraction (EC) coupling (McPherson and
Campbell, 1993). In cardiac muscle, the release of in-
tracellular Ca
 
2
 
1
 
 from the sarcoplasmic reticulum (SR)
depends on the inﬂux of extracellular calcium through
cardiac DHPRs (Nabauer et al., 1989). However, inﬂux
of extracellular calcium through voltage-gated Ca
 
2
 
1
 
channels is not a requirement for SR Ca
 
2
 
1
 
 release or
contraction in skeletal muscle (Armstrong et al., 1972;
Garcia and Beam, 1994; Dirksen and Beam, 1999).
Rather, EC coupling in skeletal muscle is thought to in-
volve a mechanical interaction between sarcolemmal
DHPRs and the skeletal muscle RyR isoform (RyR1)
(Schneider and Chandler, 1973). During EC coupling
in skeletal muscle, the DHPRs undergo voltage-driven
conformational changes that result in the activation of
SR Ca
 
2
 
1
 
 release channels (“orthograde signal”). Thus,
the DHPR in skeletal muscle functions as both a voltage
sensor for EC coupling (Ríos and Brum, 1987) and as a
voltage-gated L-channel (Tanabe et al., 1988).
 
Interestingly, the presence of the RyR1 protein pro-
 
motes the Ca
 
2
 
1
 
 conducting activity and accelerates the
 
Portions of this work were previously published in abstract form
 
(Avila, G., and R.T. Dirksen. 2000. 
 
Biophys. J. 
 
78:427a).
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activation of skeletal L-channels (“retrograde signal”)
(Fleig et al., 1996; Nakai et al., 1996). This ﬁnding was
based, in part, on experiments involving cultured skele-
tal myotubes derived from mice homozygous for a dis-
rupted RyR1 gene (RyR1-knockout or dyspedic mice;
Takeshima et al., 1994; Nakai et al., 1996). Compared
with normal myotubes, dyspedic myotubes exhibit a dra-
matic reduction in the density of L-current (Fleig et al.,
1996; Nakai et al., 1996). Moreover, expression of RyR1
in dyspedic myotubes enhances L-current in the ab-
sence of a change in intramembrane charge movement
(Nakai et al., 1996). These observations led to the con-
clusion that RyR1 promotes the Ca
 
2
 
1
 
 channel activity of
the skeletal muscle DHPR in a manner that is indepen-
dent of L-channel expression. Moreover, this ability
seems to be a unique property of RyR1 since the cardiac
isoform (RyR2) is incapable of restoring either EC cou-
pling or robust skeletal L-currents in dyspedic myotubes
(Nakai et al., 1997). Thus, the signaling between the
skeletal muscle DHPR and RyR1 is bidirectional, such
that the channel activity associated with each protein is
strongly dependent upon this unique interaction.
Interaction between intracellular signaling mole-
cules, such as G-proteins (for review, see Dolphin,
1998) and proteins of the synaptic core complex
(SNARE proteins) (for review, see Catterall, 1999),
markedly alter the functional properties of voltage-
dependent Ca
 
2
 
1
 
 channels. Thus, the reciprocal nature of
the interaction between the DHPR and RyR in skeletal
muscle appears to represent an additional example of a
voltage-gated Ca
 
2
 
1
 
 channel that is functionally modu-
lated by interaction with an intracellular signaling part-
ner. The orthograde and retrograde signals of skeletal
muscle EC coupling appear to be mediated by the in-
tracellular loop that links the second and third internal
homology repeats (II-III loop) of the skeletal muscle
DHPR (Tanabe et al., 1990; Nakai et al., 1998a; Grab-
ner et al., 1999). However, results from the expression
of chimeric RyRs into dyspedic myotubes indicate that
these two signals are localized to distinct regions within
RyR1 (Nakai et al., 1998b). Thus, although dyspedic
myotubes provide an excellent model for probing
structure/function relationships of RyR1 on skeletal
muscle EC coupling, the precise inﬂuence of RyR1 on
the fundamental properties of skeletal L-channels has
yet to be fully elucidated. Here, we describe experi-
ments designed to characterize the inﬂuence of the
RyR1 protein on the biophysical and pharmacological
properties of the skeletal L-channel. Our data demon-
strates that L-currents recorded from normal and dys-
pedic myotubes exhibit two distinct kinetic components
that are equivalently enhanced by RyR1. In addition,
our results indicate that RyR1 inﬂuences L-channel ex-
pression, activation kinetics, modulation by DHP ago-
nists, and divalent conductance.
 
METHODS
 
Preparation of Normal and Dyspedic Myotubes
 
Primary cultures of myotubes were prepared from skeletal mus-
cle of newborn normal and dyspedic mice as described previ-
ously (Nakai et al., 1996). The presence (or absence) of RyR1
mutant alleles was determined by PCR analysis on tail snip tissue
obtained from each animal used to generate cultures. Thus, each
individual culture was identiﬁed as homozygous normal (
 
1
 
/
 
1
 
),
heterozygous normal (
 
1
 
/
 
2
 
), or dyspedic (
 
2
 
/
 
2
 
). Data obtained
from homozygous and heterozygous normal cultures were ulti-
mately pooled together since no signiﬁcant differences in macro-
scopic L-channel activity were observed between all normal myo-
tubes (see Table I). Expression of RyR1 in dyspedic myotubes was
performed as previously described (Dirksen and Beam, 1999). In
brief, myotubes were microinjected (Tanabe et al., 1988) into a
single nucleus with wild-type RyR1 cDNA (0.5 
 
m
 
g/
 
m
 
l) 6–8 d after
the initial plating of myoblasts and were examined electrophysio-
logically 2–4 d later. Expressing myotubes were identiﬁed by ob-
serving contractions in response to external electrical stimula-
tion (8.0 V, 10–30 ms). In some experiments, expressing myo-
tubes were identiﬁed by the development of green ﬂuorescence
2–4 d after coinjection with a mixture of RyR1 cDNA (0.5 
 
m
 
g/
 
m
 
l)
and a cDNA expression plasmid encoding an enhanced green
ﬂuorescent protein (0.01 
 
m
 
g/
 
m
 
l) (Grabner et al., 1999).
 
Electrophysiologic Measurements
 
Whole-cell patch-clamp experiments were carried out at room
temperature (20–22
 
8
 
C), 7–11 d after the initial plating of myo-
blasts. For all experiments, the holding potential was 
 
2
 
80 mV.
T-type Ca
 
2
 
1
 
 currents were eliminated by a conditioning prepulse
consisting of a 1-s depolarization to 
 
2
 
20 mV followed by a 25-ms
repolarization to 
 
2
 
50 mV before each test pulse (Adams et al.,
1990; Dirksen and Beam, 1999). Currents were recorded with ei-
ther a Dagan 3900A (Dagan Corp.) or Axopatch 200A (Axon In-
struments Inc.) ampliﬁer and ﬁltered at 2 kHz by a four-pole
Bessel ﬁlter. Data were digitized at 10 kHz using a DigiData 1200
interface (Axon Instruments, Inc.) and analyzed using the
pCLAMP (Axon Instruments, Inc.) and SigmaPlot (SPSS Inc.)
software suites. Capacitative currents were minimized (
 
.
 
90%)
using the capacitative transient cancellation feature of the ampli-
ﬁer. The remaining linear components were subtracted using a
P/3 leak subtraction protocol. Cell capacitance (C
 
m
 
) was deter-
mined by integration of the capacity transient resulting from a
 
1
 
10-mV pulse applied from the holding potential and was used
to normalize ionic (pA/pF) and gating (nC/
 
m
 
F) currents ob-
tained from different myotubes. Relatively large dyspedic myo-
tubes were used to compensate for the relatively L-current den-
sity (
 
z
 
1.0 pA/pF) found in these cells. C
 
m
 
 values were (pF): 322
 
6
 
 27 (
 
n
 
 5 
 
44), 607 
 
6
 
 55 (
 
n
 
 5 
 
38), and 454 
 
6
 
 33 (
 
n
 
 5 
 
82), for
normal myotubes, dyspedic myotubes, and all experiments, re-
spectively. The average series (access) resistance (R
 
s
 
) after com-
pensation was 1.1 
 
6
 
 0.07 M
 
V
 
 (
 
n
 
 5 
 
82), and the voltage error due
to series resistance (V
 
e
 
 
 
5 
 
R
 
s
 
 
 
3
 
 I
 
Ca
 
) was less than 
 
z
 
5 mV (for these
experiments, the average was 2.66 
 
6
 
 0.19 mV,
 
 n 
 
5 
 
82). The aver-
age time constant for charging the membrane capacitance (
 
t
 
m
 
 
 
5
 
R
 
s
 
 
 
3
 
 C
 
m
 
) was 0.37 
 
6
 
 0.02 ms (
 
n
 
 5 82) and was never larger than
1.21 ms. All data are presented as mean 6 SEM.
Macroscopic Calcium Currents
The whole-cell variant of the patch clamp technique (Hamill et
al., 1981) was used to compare the properties of macroscopic
L-currents of normal myotubes, uninjected dyspedic myotubes,
and dyspedic myotubes injected with cDNA encoding the wild-469 Avila and Dirksen
type rabbit RyR1. Patch pipettes were fabricated from borosili-
cate glass and had resistances of 1.5–2.0 MV when ﬁlled with in-
ternal solution (see below). Peak inward Ca21 currents were as-
sessed at the end of 200-ms test pulses of variable amplitude and
plotted as a function of the membrane potential (I-V curves). I-V
curves were subsequently ﬁtted according to:
(1)
where Vrev is the extrapolated reversal potential of the calcium or
barium current, V is the membrane potential during the test
pulse, I is the peak current during the test pulse, Gmax is the max-
imum L-channels conductance, VG1/2 is the voltage for half activa-
tion of Gmax, and kG is the slope factor. The activation phase of
macroscopic ionic currents was ﬁtted using one of the following
exponential functions (Eqs. 2 and 3):
(2)
(3)
where I(t) is the current at time t after the depolarization, A0,
Afast, and Aslow are the steady state current amplitudes of each
component with their respective time constants of activation (t0,
tfast, and tslow), and C represents the steady state peak current. In
all cases, the ﬁtting procedure started at the zero current level,
which corresponded to 5–7 ms after the initiation of the voltage
pulse (.10 3 tm). This approach limited artifacts introduced by
the declining phase of Qon, since the magnitude of Qon reaches
.90% of its maximal value before this time (see Fig. 1). In addi-
tion, L-currents were also recorded before and after ionic cur-
rent blockade with 0.5 mM Cd21 1 0.2 mM La31 in a separate set
of experiments. The Cd21/La31-sensitive currents lacked in-
tramembrane charge movements and exhibited nearly identical
activation kinetics as those obtained before gating current sub-
traction (data not shown). Thus, the fast component of L-current
activation described in this study is not greatly inﬂuenced by the
declining phase of the Qon gating current transient.
Intramembrane Charge Movement
Immobilization-resistant intramembrane charge movements were
measured in whole-cell mode by a method described previously
(Adams et al., 1990). Calcium currents were blocked by the addi-
tion of 0.5 mM CdCl2 1 0.2 mM LaCl3 to the extracellular record-
ing solution. This combination of Cd21 and La31 effectively blocks
ionic calcium currents carried through calcium channels in nor-
mal myotubes (Adams et al., 1990; Garcia and Beam, 1994; Dirk-
sen and Beam, 1995). To prevent ampliﬁer saturation, voltage
clamp command pulses were exponentially rounded with a time
constant of 240 ms. The amount of immobilization-resistant charge
movement was estimated by integrating the transient of charge
that moved outward after the onset of the test pulse (Qon). The
magnitude of the maximum immobilization-resistant charge move-
ment (Qmax) was estimated by ﬁtting the Qon data according to:
(4)
where VQ1/2 and kQ have their usual meanings with regard to
charge movement.
Recording Solutions
For measurements of macroscopic ionic and gating currents, the
internal solution consisted of (mM): 140 Cs-aspartate, 10 Cs2-
I Gmax VV rev – () 1V G1 2 ¤ V – () kG ¤ [] exp + {} ¤ , =
I t () A0 t – t0 ¤ () exp [] C + =
I t () Afast t – tfast ¤ () exp [] Aslow t – tslow ¤ () exp [] + C, + =
Qon Qmax 1V Q1 2 ¤ V – () kQ ¤ [] exp + {} , ¤ =
EGTA, 5 MgCl2, and 10 HEPES, pH 7.40 with CsOH. Macro-
scopic calcium currents were recorded in an external solution
containing (mM): 145 TEA-Cl, 10 CaCl2, 0.003 TTX (Alomone
Laboratories), and 10 HEPES, pH 7.40 with TEA-OH. For mea-
surements of macroscopic barium currents, 10 mM BaCl2 was
substituted for the 10 mM CaCl2 in the external solution. The ex-
ternal calcium current recording solution was supplemented with
0.5 mM CdCl2 1 0.2 mM LaCl3 for measurements of intramem-
brane charge movement. For some experiments, the inﬂuence of
RyR1 on the stimulatory action of (2) Bay K 8644 (0.005 mM), a
pure DHP agonist, was evaluated after addition to the external
calcium current recording solution. Except where noted, all
chemical reagents were obtained from Sigma Chemical Co.
RESULTS
Dyspedic Myotubes Exhibit a Reduction in
Immobilization-resistant Charge Movement
If the gating charge moved is similar for channels with
different Pos, then the density of channel proteins can be
estimated from the magnitude of the maximal immo-
bilization-resistant intramembrane charge movement
(Qmax) (Adams et al., 1990; Nakai et al., 1996). The val-
ues of Qmax reported for normal myotubes originating
from the dysgenic line of mice (which lack a functional
copy of the skeletal DHPR gene) have varied (nC/mF):
7.9 6 1.4 (Adams et al., 1990), 7.2 6 0.5 (Dirksen and
Beam, 1995), 5.6 6 2.6 (Nakai et al., 1996), and 5.1 6 0.9
(Garcia et al., 1994). This variability, coupled with the
fact that the dyspedic mice were constructed from a sepa-
rate mouse lineage, prompted us to compare the magni-
tude of Qmax in dyspedic myotubes with myotubes de-
rived from their phenotypically normal littermates (nor-
mal myotubes). The voltage dependence of the charge
movement obtained from these experiments is illus-
trated in Fig. 1. On average, the Qmax values of normal
and dyspedic myotubes were 7.5 6 0.8 (n 5 17) and 4.5
6 0.4 (n 5 14) nC/mF, respectively. Thus, dyspedic myo-
tubes exhibit a 40% reduction in Qmax compared with
the magnitude of Qmax obtained from normal myotubes
derived from their phenotypically normal littermates.
This 40% reduction in the magnitude of Qmax in dys-
pedic myotubes is quantitatively similar to previous stud-
ies that reported a reduction in total DHP binding in dys-
pedic muscle (25%, Fleig et al., 1996; 50%, Buck et al.,
1997). Interestingly, the VQ1/2 of Qon in dyspedic myo-
tubes was z10 mV more hyperpolarized than that of nor-
mal myotubes (Fig. 1 C and Table I). Thus, the RyR1 pro-
tein not only promotes the long-term functional expres-
sion of DHPRs, but also modiﬁes the voltage sensitivity of
DHPR’s mediated gating currents. The difference in
DHPR’s gating current sensitivity to activation by voltage
(i.e., VQ1/2) was reversed 2–4 d after nuclear injection of
dyspedic myotubes with cDNA encoding wild-type RyR1
(Fig. 1 C and Table I). However, the restoration of Qon
voltage sensitivity by RyR1 expression in dyspedic myo-
tubes occurred in the absence of an effect on Qmax (see470 Impact of RyR1 on Skeletal L-Channels
also Nakai et al., 1996), suggesting that the restoration of
a “normal” level of Qmax may reﬂect a slower process in-
volving protein synthesis and/or membrane trafﬁcking.
Null mutations of a single allele in a diploid organism
could potentially result in a reduced probability of gene
expression, and thus lead to haploinsufﬁciency. There-
fore, we have investigated whether the presence of a sin-
gle wild-type RyR1 allele is sufﬁcient to supply the num-
ber of ryanodine receptors required to sustain normal
L-channel activity. With this in mind, normal myotubes
were genotyped and divided into two groups: homozy-
gous normal (1/1) and heterozygous normal (1/2)
for the wild-type RyR1 allele. However, no signiﬁcant
(P . 0.4) differences were found in the voltage-depen-
dent parameters of either L-channel conductance or
charge movement (Table I) between these two genotypic
groups. These data are in agreement with morphological
studies that indicate that muscle ﬁbers obtained from ho-
mozygous and heterozygous normal embryos are struc-
turally indistinguishable (Takekura et al., 1995). Thus,
data from homozygous and heterozygous normal myo-
tubes were pooled together in all subsequent analyses.
Dyspedic myotubes exhibit a very modest amount of
slowly activating L-current, which is greatly enhanced
2–4 d after nuclear injection of wild-type RyR1 cDNA (Na-
kai et al., 1996; Fig 2, A and B). In our experiments, the
average peak L-currents were (at 130 mV) (pA/pF):
12.1 6 0.6 (n 5 27), 1.1 6 0.4 (n 5 9), and 8.4 6 0.6
(n 5 6) for normal, dyspedic, and RyR1-expressing dys-
pedic myotubes, respectively. Since normal myotubes
exhibit a larger Qmax compared with uninjected and
RyR1-expressing dyspedic myotubes (Fig. 1 and Table
I), we normalized peak L-current data by the Qmax value
for each myotube (current-to-charge ratio). The nor-
malized data (Fig. 2 C) demonstrates that expression of
RyR1 in dyspedic myotubes restores the current-to-
charge ratio at every potential and suggests that equiva-
lent fractions of L-channels are upregulated in normal
Figure 1. Voltage dependence of charge movements. (A) In-
tramembrane charge movements recorded from normal (top),
dyspedic (middle), and RyR1-expressing dyspedic (bottom) myo-
tubes. The recordings for each data set were elicited by 20-ms de-
polarizations to the indicated voltages (mV). (B) Average voltage
dependence of charge movements (Qon) obtained from 17 normal
(d), 14 dyspedic (s) and 7 RyR1-expressing dyspedic (e) myo-
tubes. Values of Qon were determined by integrating the “on” out-
ward transient at each membrane potential and normalized to cell
capacitance (Cm). The average values (6SEM) for the parameters
obtained by ﬁtting each myotube within a group separately to Eq.
4 are given in Table I. The smooth solid lines through the data
were generated by using Eq. 4 and the average values (Q-V) given
in Table I. (C) The Qon values from B were normalized to their
maximal value and plotted versus Vm.
TABLE I
Parameters of Fitted I-V and Q-V Curves
n I-V data Q-V data
I-V Q-V Gmax VG1/2 kG Qmax VQ1/2 kQ Gmax/Qmax
nS/nF mV mV nC/mF mV mV nS/pC
(1/1) 13 10 250 6 19 13.7 6 1.0 5.1 6 0.2 8.1 6 1.1 23.1 6 0.9 11.6 6 0.5 35.1 6 3.7 (10)
(1/2) 14 7 245 6 12 11.7 6 1.0 5.7 6 0.3 6.6 6 1.3 25.2 6 3.1 12.3 6 2.0 43.5 6 9.3 (7)
Normal 27 17 247 6 11 12.7 6 0.9 5.4 6 0.2 7.5 6 0.8 24.0 6 1.3 11.9 6 0.4 38.6 6 4.3 (17)
Dyspedic 9 14 33.9 6 9.3*‡ 19.7 6 1.1*‡ 6.9 6 0.3*‡ 4.5 6 0.4* 214.0 6 1.5*‡ 11.6 6 0.6 8.5 6 1.7*‡ (9)
RyR-1 expressing 6 7 181 6 11* 13.5 6 0.8 4.8 6 0.2 4.8 6 0.7 0.0 6 2.8 11.2 6 0.5 41.9 6 11 (6)
I-V and Q-V data are from the number of myotubes indicated (n). Average values (6SEM) were obtained by fitting each myotube within a group separately
to the appropriate equation (I-V, Eq. 1; Q-V, Eq. 4). The numbers of experiments used to calculate Gmax/Qmax are indicated in parenthesis. The genotype
of each culture used was determined by PCR analysis as described in methods. RyR-1–expressing dyspedic myotubes were subject to patch-clamp
experiments 2–4 d after cDNA microinjection. Qdys (see Adams et al., 1990) was not subtracted from Qmax in calculations of Gmax/Qmax as done previously
(Nakai et al., 1996), since Idys does not appear to be present in normal or dyspedic myotubes (see discussion).
*Compared with normal (P , 0.001), ‡compared with RyR-1 expressing (P , 0.001).471 Avila and Dirksen
and RyR1-expressing dyspedic myotubes. The approxi-
mately ﬁvefold difference in the current-to-charge (Fig.
2 C) and conductance-to-charge (Gmax/Qmax) ratios be-
tween dyspedic myotubes and both normal and RyR1-
expressing dyspedic myotubes (Table I) supports the
conclusion that RyR1 increases L-channel open proba-
bility and/or unitary conductance (Nakai et al., 1996).
RyR1 Alters Two Kinetic Components of L-Current Activation
The slow activation time course of skeletal L-current in
cultured mouse myotubes has often been approximated
by ﬁtting the data to a single exponential function
(Tanabe et al., 1990; Dirksen and Beam, 1995; Strube et
al., 1996; Beurg et al., 1997). However, L-current activa-
tion is apparently more complex. An adequate (x2 ,
0.005) quantitative description of activation in BC3H1
cells requires two exponential components (Caffrey,
1994). Fig. 3 A demonstrates that activation of L-cur-
rents in cultured skeletal myotubes also involves two ki-
netically distinct components. Single exponential ﬁtting
of normal L-currents failed to adequately describe cur-
rent activation, particularly early during the depolariza-
tion (Fig. 3 A, left). However, ﬁtting the data with the
sum of two exponentials greatly improved (indicated by
a .16-fold reduction in the value of x2) the description
of L-current activation (Fig. 3 A, right). The biexponen-
tial nature of the activation of the calcium current is
best appreciated by replotting the normalized currents
on a semilogarithmic scale (Fig. 3 A, bottom). The use
of three exponential components did not signiﬁcantly
improve the ﬁt of the data. The activation time course
of the residual calcium current recorded from dyspedic
myotubes was also best described by the sum of two ex-
ponential components (data not shown).
The second order exponential ﬁtting procedure re-
sulted in the extraction of the steady state amplitudes
(Afast and Aslow) and corresponding activation time con-
stants (tfast and tslow) that comprise the macroscopic
L-current. The inﬂuence of RyR1 on the amplitudes and
time constants of macroscopic L-currents at 140 mV is
summarized in Fig. 3, B–D. Amplitudes and time con-
stants were compared between normal (N), dyspedic (Y),
and RyR1-expressing (R) dyspedic myotubes after 200-ms
depolarizations to 140 mV, a potential at which L-cur-
rent conductance is maximal (Adams et al., 1990; Garcia
et al., 1994; Dirksen and Beam, 1995). This analysis re-
vealed that the marked reduction in dyspedic L-current
arises from a parallel decrease in both Afast (22.20 6 0.37
and 20.36 6 0.03 for normal and dyspedic myotubes, re-
spectively) and Aslow (210.02 6 1.04 and 21.14 6 0.11
for normal and dyspedic myotubes, respectively). Thus,
the fractional contribution of each component to the
macroscopic L-current was similar in the presence and
absence of RyR1 (Fig. 3 C). Interestingly, the faster over-
all activation of dyspedic L-currents (Nakai et al., 1996)
arises from an approximately twofold reduction in both
tfast and tslow (Fig. 3 D). Nuclear injection of dyspedic my-
otubes with wild-type RyR1 cDNA resulted in a marked
increase in both Afast and Aslow and also a corresponding
increase in tfast and tslow (Fig. 3, B–D). Thus, the parallel
dependence of both the amplitudes and time constants
of the macroscopic L-current on the presence of RyR1
indicates that skeletal L-channels in cultured myotubes
exhibit two distinct kinetic gating modes, each of which
are modiﬁed by interaction with RyR1.
Bay K 8644 Accelerates Dyspedic L-Current Activation 
through a Preferential Increase in Afast
The data illustrated in Table I and Fig. 3 suggest that
RyR1 inﬂuences the functional conformation of the
Figure 2. Voltage dependence of L-currents. (A) Family of cal-
cium currents recorded from normal (top), dyspedic (middle),
and RyR-1-expressing (bottom) dyspedic myotubes. The currents
were elicited by 200-ms depolarizations from 250 mV to the indi-
cated potential (mV) following a prepulse protocol (see methods)
used to inactivate T-type Ca21 currents. Vertical calibration corre-
sponds to 6 pA/pF for the normal and RyR1-expressing myotubes
and 2 pA/pF for the dyspedic myotube. (B) Average peak current
density plotted as a function of membrane potential (Vm). Data
were obtained from 13 RyR1 homozygous (1/1) (m), 14 RyR1
heterozygous (1/2) (.), 9 dyspedic (s), and 6 RyR1-expressing
dyspedic (e) myotubes. The average values (6SEM) for the pa-
rameters obtained by ﬁtting each myotube within a group sepa-
rately to Eq. 1 are given in Table I. The smooth solid lines through
the data were generated by using Eq. 1 and the average values (I-V)
given in Table I. Data for homozygous (1/1) and heterozygous
(1/2) normal myotubes were each well represented by a single
solid line obtained from the combined data (13 1/1 and 14 1/2
myotubes). (C) Normal and RyR1-expressing dyspedic myotubes
exhibit similar average current-to-charge ratios. Current-to-charge
ratios were calculated by dividing the peak calcium current at each
membrane potential by the maximum immobilization-resistant
charge movement (Qmax) that was determined for each myotube.
Data were obtained from 17 normal (d, 10 1/1 and 7 1/2), 9
dyspedic (s), and 6 RyR1-expressing dyspedic (e) myotubes.472 Impact of RyR1 on Skeletal L-Channels
skeletal L-channel. Since DHP modulation of the activ-
ity and voltage dependence L-channels is state depen-
dent (Hille, 1992), we set out to evaluate the effects of
RyR1 on the DHP modulation of L-channels in cul-
tured skeletal myotubes. We ﬁrst compared whole-cell
calcium currents in the absence (control) and pres-
ence of the pure DHP agonist, (2) Bay K 8644 (5 mM).
Fig. 4 A shows representatives L-currents recorded
from normal (left) and dyspedic (right) myotubes elic-
ited by 200-ms depolarizations to 140 mV. To empha-
size kinetic differences, control traces are shown after
normalization to the peak current recorded in the pres-
ence of (2) Bay K 8644 (5 mM). In both myotubes, 5
mM (2) Bay K 8644 produced a 46% increase in peak
calcium current (see also Fig. 5, A and C) and a signiﬁ-
cant acceleration in the activation time course.
As demonstrated in Fig. 3 A, L-current activation was
clearly best described by the sum of two exponential
functions, and this becomes even more evident in the
presence of DHP (where the second-order ﬁt reduced
x2 .43-fold, Fig. 4 A, left). This analysis revealed that at
140 mV the DHP-induced acceleration in L-channel
activation kinetics in normal myotubes arises primarily
from a preferential increase in the amplitude of the fast
component (Afast) of L-current (Fig. 4 B, left). Speciﬁ-
cally, (2) Bay K 8644 caused a signiﬁcant increase (83
6 12%, n 5 6) in the magnitude of Afast, without signif-
icantly altering Aslow. However, the time constants of
each component (tfast and tslow) were not signiﬁcantly
altered in the presence of the DHP agonist (Fig. 4 B,
right). In dyspedic myotubes at 140 mV, (2) Bay K
8644 induced an increase in Afast (174 6 30%, n 5 7)
without signiﬁcantly altering the magnitudes of Aslow,
tfast, or tslow (Fig. 4 C). Consequently, in dyspedic myo-
tubes, the DHP agonist increased the relative contribu-
tion of Afast to the total L-current (at 140 mV, Afast/
[Afast 1 Aslow] was 0.24 6 0.02 in control and 0.49 6
0.02 in 5 mM (2) Bay K 8644, P , 0.001). Thus, at 140
mV, (2) Bay K 8644 preferentially augmented the mag-
nitude of Afast in both normal and dyspedic myotubes
without altering Aslow, tfast, or tslow.
The data described in Fig. 4 were obtained for test
pulses to 140 mV, a potential at which L-channel con-
ductance is maximal in both the presence and absence
of DHP agonist. The effects of (2) Bay K 8644 (5 mM)
on the voltage dependence of macroscopic skeletal
L-currents and its component parts (Afast and Aslow) are
summarized in Fig. 5. The peak I-V relationships of nor-
mal (Fig. 5 A) and dyspedic (C) myotubes were ob-
tained in the absence (d) and presence (s) of (2) Bay
K 8644 (5 mM). In both types of myotubes, the DHP ag-
onist produced both a similar increase in total L-current
density and a hyperpolarizing shift (z10 mV, Table II)
in the macroscopic I-V relation. However, these effects
on the overall macroscopic currents arise from qualita-
tively distinct alterations in the two kinetic components
of skeletal L-current. In Fig. 5, the magnitudes of Afast
and Aslow in normal (B) and dyspedic (D) myotubes
were normalized by the average peak control value for
Figure 3. L-currents are best described by the sum of two expo-
nential equations. (A) A representative calcium current (top) is il-
lustrated for a normal myotube after 200-ms depolarizations to 140
mV. L-current activation was ﬁtted according to either ﬁrst (left) or
second (right) order exponential functions (h), as described in
methods. The amplitudes and time constants obtained from the
single-order exponential ﬁtting was 9.26 pA/pF and 61.4 ms. Sec-
ond-order exponential ﬁtting resulted in the following values: Aslow
5 8.10 pA/pF, tslow 5 96.2 ms, Afast 5 2.97 pA/pF, and tfast 5 10.4
ms. (Bottom) Semilogarithmic plots of the calcium current trace
normalized to the peak current superimposed with the results of ei-
ther a ﬁrst (left) or second (right) order exponential ﬁt (h). The
semilogarithmic plots demonstrate that an adequate description of
current activation clearly requires two distinct exponential compo-
nents (with time constants, tfast and tslow). (B–D) Average parame-
ters obtained from second-order exponential ﬁtting of L-currents
obtained at 140 mV. Bars represent the average values from a total
of six normal (N), seven dyspedic (Y), and eight RyR1-expressing
dyspedic (R) myotubes. Data are shown for (B) current density, (C)
relative amplitude (shown as Ax/[Afast 1 Aslow], where “Ax” repre-
sents the absolute steady state amplitude of either the fast or slow
components), and (D) the time constants associated with the fast
(tfast) and slow (tslow) components of the total current.473 Avila and Dirksen
each data set (Aslow and Afast were: 11.89 6 1.10 and 2.30
6 0.40 pA/pF for normal myotubes, and 1.23 6 0.16
and 0.47 6 0.06 pA/pF for dyspedic myotubes). This
analysis revealed that, even under control conditions,
Afast activates z10 mV more hyperpolarized than Aslow.
In normal myotubes, (2) Bay K 8644 increased (up to
approximately twofold) the normalized magnitude of
both Afast and Aslow. In addition, the DHP-induced hyper-
polarizing shift in the voltage dependence of L-channel
activation is reﬂected as a selective shift in the voltage
dependence of Aslow. Interestingly, (2) Bay K 8644 pro-
duced an approximately threefold increase in Afast in
the absence of an alteration in the magnitude of Aslow in
dyspedic myotubes. The remarkable DHP insensitivity
of Aslow in dyspedic myotubes indicates that the RyR1
protein imparts a strong inﬂuence on the state-depen-
dent action of DHP agonists on skeletal L-channels.
RyR1 Modiﬁes Skeletal L-Channel Divalent Conductance
Equimolar substitution of Ba21 for extracellular Ca21
produces an increase in peak L-current and a hyperpo-
larizing shift in the voltage dependence of channel acti-
vation in cardiac muscle (Kass and Sanguinetti, 1984).
Increased L-current amplitude has been attributed to a
higher L-channel conductance to Ba21 (Fox et al.,
1987), while the shift in channel activation involves dif-
ferences in the ability of Ba21 and Ca21 ions to screen
external surface charges (Hille, 1992). A similar substi-
tution produces a smaller increase in L-current density
and a similar hyperpolarizing shift in channel activa-
tion in skeletal muscle (Tanabe et al., 1990). We investi-
gated the inﬂuence of the RyR1 protein on the effects
of equimolar substitution of Ba21 for extracellular Ca21
on skeletal L-currents in Fig. 6. In both normal and dys-
pedic myotubes, L-channel activation was shifted z10
mV in the hyperpolarized direction upon replacement
of extracellular Ca21 with Ba21 (Fig. 6; Table II). In nor-
mal myotubes, peak L-current magnitude (Fig. 6 B, a)
and conductance (Table II) were increased (P , 0.01)
nearly 40% with Ba21 as the extracellular charge car-
rier. In contrast, peak L-current magnitude (Fig. 6 B, c)
and conductance (Table II) were unaltered upon the
identical divalent substitution in dyspedic myotubes.
The relative contribution of Afast and Aslow to the mac-
roscopic Ca21 and Ba21 currents (Fig. 6 B, b and d) were
extracted by ﬁtting a second-order exponential function
to the activation phase of the ionic currents (Fig. 6 A).
Substitution of Ba21 for extracellular Ca21 increased
both Afast and Aslow in normal myotubes (Fig. 6 B, b) with-
out greatly altering either tfast or tslow (data not shown).
The identical divalent substitution failed to signiﬁcantly
alter the magnitude of either Afast or Aslow in dyspedic my-
otubes (Fig. 6 B, d). Nevertheless, extracellular Ba21 sub-
stitution caused a hyperpolarizing shift in the voltage de-
pendence of both Afast and Aslow in normal and dyspedic
myotubes. Thus, the skeletal muscle ryanodine receptor
appears to inﬂuence relative L-channel divalent conduc-
tance, but not the differential ability of Ca21 and Ba21
ions to modify external surface charge. These data sug-
gest that the interaction of RyR1 with the skeletal muscle
DHPR may exert long-range effects on the functional
conformation of the pore of the skeletal L-channel. How-
ever, a direct evaluation of the effects of RyR1 on skeletal
L-channel selectivity must await a systematic determina-
tion of the monovalent and divalent permeability se-
quence of L-channels in normal and dyspedic myotubes.
Figure 4. Effects of DHP agonist on the two components of mac-
roscopic L-current. (A) Representative L-currents recorded from a
normal (left) and a dyspedic (right) myotube in the absence (con-
trol) and presence of 5 mM (2) Bay K 8644. Current traces were
ﬁtted according to a second-order exponential function (h, super-
imposed over raw data). Both control traces have been scaled
(1.463) to the peak of the L-current recorded in the presence of
DHP. The vertical calibration corresponds to 3 and 0.3 pA/pF for
the normal and dyspedic L-current traces recorded in the pres-
ence of DHP, respectively. (B) Average values obtained for current
density (left) and tact (right) obtained from second-order expo-
nential ﬁtting of data obtained at 140 mV. Data were tabulated
from the analysis of calcium currents that were recorded in the ab-
sence (black bars) and presence (white bars) of 5 mM (2) Bay K
8644. Values represent means 6 SEM of six experiments in normal
myotubes and seven experiments in dyspedic myotubes. (2) Bay K
8644 selectively augmented the fast amplitude (Afast) component
in both normal (z1.8-fold) and dyspedic (z2.7-fold) myotubes,
without signiﬁcantly altering tfast or tslow.474 Impact of RyR1 on Skeletal L-Channels
DISCUSSION
In skeletal muscle, the coupling of sarcolemmal depo-
larization to the release of SR calcium is thought to in-
volve a direct physical interaction between the DHPR
and the RyR1. If the interaction of RyR1 with the
DHPR stabilizes certain L-channel conformational
states by altering transition rates between states, then
disruption of this interaction may result in altered
L-channel function. However, no study has systematically
characterized the inﬂuence of RyR1 on the biophysical
and pharmacological properties of the skeletal L-cur-
rent. Consequently, we have evaluated the inﬂuence of
RyR1 on the expression level, voltage dependence, acti-
vation rate, DHP modulation, and divalent conduc-
tance of the skeletal L-channel. Our results indicate
that the density of functional sarcolemmal L-channels
is reduced by z40% in dyspedic myotubes compared
with that of myotubes derived from their phenotypi-
cally normal littermates. We also demonstrated that
dyspedic L-currents exhibit accelerated activation (tfast
and tslow), a greater separation between Q-V and G-V re-
lationships ([VG1/2 2 VQ1/2] was 16.7, 33.7, and 13.5 mV
for normal, dyspedic, and RyR1-expressing dyspedic
myotubes, respectively), and similar macroscopic con-
ductances to Ca21 and Ba21. The ability of RyR1 to en-
hance the coupling between charge movement and
pore opening (i.e., reduce Q-V/G-V separation) and al-
ter the relative conductance to divalent ions (Ca21 ver-
sus Ba21) suggests that RyR1 imparts long-range effects
on the conformational state of the pore of the skeletal
L-channel. In addition, (2) Bay K 8644 increased the
magnitude of both the fast (Afast) and slow (Aslow) com-
ponents of the total L-current in normal myotubes, but
only enhanced the fast component in dyspedic myo-
tubes. Thus, our results indicate that the presence of
Figure 5. Voltage dependence of the stimula-
tory effects of DHP agonist on the fast and slow
components of macroscopic L-current. Average
L-current–voltage relationships obtained from six
normal (A) and seven dyspedic (C) myotubes in
the absence (d) and presence (s) of 5 mM (2)
Bay K 8644. (B and D) Afast and Aslow were deter-
mined for current traces from 0 to 140 mV (see
methods) and normalized to their maximal value
obtained in the absence of DHP. Normalized Afast
and Aslow values were then plotted as a function of
membrane potential (Vm). Absolute peak values
for the two components of the calcium current in
the absence of DHP were (pA/ pF): Aslow 5 11.89
6 1.10, Afast 5 2.30 6 0.40 for normal myotubes,
and Aslow 5 1.23 6 0.16, Afast 5 0.47 6 0.06 for
dyspedic myotubes. Neither tfast nor tslow were sig-
niﬁcantly altered by 5 mM (2) Bay K 8644 at any
potential (data not shown).
TABLE II
Parameters of Fitted I-V Curves
Normal myotubes Dyspedic myotubes
n Gmax VG1/2 kG n Gmax VG1/2 kG
nS/nF mV mV nS/nF mV mV
Control 6 283 6 22 14.9 6 0.7 5.4 6 0.2 7 51.1 6 5.4 18.0 6 0.6 6.9 6 0.6
(2) Bay K 8644 6 398 6 25* 2.91 6 1.6* 4.5 6 0.4 7 59.9 6 5.1 9.61 6 1.2* 6.9 6 0.4
10 Ca21 11 254 6 9.2 12.5 6 1.3 4.8 6 0.2 8 42.7 6 2.7 15.0 6 1.2 6.9 6 0.2
10 Ba21 11 348 6 24‡ 2.39 6 1.3‡ 3.7 6 0.2‡ 8 50.0 6 2.9 6.87 6 1.1‡ 5.6 6 0.3‡
Values (mean 6 SEM) were obtained as described in Table I. Data are form the number of myotubes indicated (n).
*Compared with control (P , 0.01), ‡compared with 10 Ca21 (P , 0.01).475 Avila and Dirksen
RyR1 in skeletal muscle imparts a strong inﬂuence on
several essential properties of the skeletal L-channel.
RyR1 Promotes L-Channel Expression
Previous studies have demonstrated that dyspedic mus-
cle exhibits a 25–50% reduction in total DHP binding
capacity compared with normal muscle (Fleig et al.,
1996; Buck et al., 1997). Our ﬁnding that Qmax of dys-
pedic myotubes is reduced z40% compared with nor-
mal myotubes is in agreement with these reports and in-
dicates that RyR1 promotes DHPR expression in skeletal
muscle. However, this 40% reduction in DHPR expres-
sion cannot fully account for the z90% reduction in the
value of Gmax in dyspedic myotubes. Even after normal-
ization of peak currents (Fig. 2) and Gmax (Table I) by
Qmax, DHPRs in normal myotubes possess an approxi-
mately ﬁvefold higher Ca21-conducting activity com-
pared with that of dyspedic myotubes. Thus, our results
support the conclusion of Nakai et al. (1996) that RyR1
enhances either the open probability and/or the uni-
tary conductance of skeletal L-channels. Interestingly,
DHPR Ca21-conducting activity (Ica/Qmax and Gmax/
Qmax) was completely restored 2–4 d after nuclear injec-
tion of dyspedic myotubes with RyR1 cDNA without al-
tering the magnitude of Qmax. Apparently, introduction
of RyR1 proteins into dyspedic myotubes restores exist-
ing L-channel activity before increasing DHPR expres-
sion (as reﬂected in Qmax). It will be important for fu-
ture experiments to determine whether or not long-
term expression of RyR1 is able to restore Qmax to a value
similar to that of normal myotubes and whether these
changes are also associated with alterations in EC cou-
pling. Interestingly, the preferential inﬂux of Ca21
through L-channels activates the calcium/calcineurin/
NF-ATc transcription pathway and results in the induc-
tion of the type 1 1,4,5-inositol trisphosphate receptor in
Figure 6. Voltage dependence of the effects of
divalent charge carrier on the fast and slow com-
ponents of macroscopic L-current. (A) Represen-
tative L-currents recorded from a normal (left)
and dyspedic (right) myotube obtained in the
presence of either 10 mM extracellular Ca21
(Ca21) or 10 mM extracellular Ba21 (Ba21). Cur-
rent traces were ﬁtted according to a second-
order exponential function (h, superimposed over
raw data). The vertical calibration corresponds to
2.5 and 0.5 nA for the normal and dyspedic myo-
tubes, respectively. (B) L-current–voltage relation-
ships from 11 normal (a) and seven dyspedic (c)
myotubes recorded as in A. Aslow and Afast values
(b and d) were obtained and normalized as de-
scribed in Fig. 5. Absolute peak values for the two
components of the calcium current were (pA/
pF): Aslow 5 10.89 6 0.80, Afast 5 2.28 6 0.36 for
normal myotubes, and Aslow 5 1.12 6 0.12, Afast 5
0.47 6 0.07 for dyspedic myotubes.476 Impact of RyR1 on Skeletal L-Channels
hippocampal neurons (Graef et al., 1999). Thus, it will
be important to determine whether the enhancement
of L-channel expression in skeletal myotubes also in-
volves activation of a calcium-mediated transcription
pathway (via Ca21 inﬂux and/or SR Ca21 release).
Two Kinetic Components of L-Current Activation
The activation kinetics of skeletal L-currents in cul-
tured myotubes has often been approximated by ﬁtting
the activation time course to a single exponential func-
tion. This approach has provided a convenient means
for making qualitative comparisons in channel kinetics
under different conditions (Tanabe et al., 1991; Dirk-
sen and Beam, 1995; Beurg et al., 1997). However, a
precise quantitative description of skeletal L-current ac-
tivation appears to require the sum of two exponential
components (Fig. 3; and see Caffrey, 1994). For exam-
ple, Caffrey (1994) demonstrated that macroscopic
L-current activation in BC3H1 myotubes was best de-
scribed by the sum of two ascending exponential terms
with time constants (t1 5 2–20 ms and t2 5 10–200 ms)
similar to those reported here. Moreover, the voltage
dependence and relative contribution of the faster
component in BC3H1 cells (z25% at 140 mV) is com-
parable with our results using primary myotube cul-
tures. Our analyses indicate that while a single expo-
nential often results in a reasonable approximation of
L-channel activation at strong depolarizations (.20
mV), two activation terms are clearly required under
conditions that enhance the relative contribution of
the fast component of L-current activation. An increase
in the relative contribution of Afast results in a clear
bi-exponential activation for L-currents activated at
threshold potentials (e.g., 210 mV) and for L-currents
in dyspedic myotubes treated with (2) Bay K 8644 (Fig.
4 A). In addition, we have recently reported that pro-
longed depolarization markedly increases the relative
contribution of Afast to the total L-current, resulting in a
clearly bi-exponential L-channel activation time course
(O’Connell and Dirksen, 2000).
Apparent channel activation can be altered when a
signiﬁcant degree of inactivation occurs during the acti-
vation process. Thus, inactivation occurring during our
200-ms test pulses could inﬂuence the kinetic properties
of L-channel activation (Afast, tfast, Aslow, and  tslow) re-
ported here. Since we have not systematically character-
ized inactivation in normal and dyspedic myotubes in
this study, we cannot rule out a possible contribution of
inactivation to the effects of RyR1 on the kinetic proper-
ties of L-channel activation. However, any effects of inac-
tivation on apparent L-channel activation would be an-
ticipated to be minimal in our experiments since inacti-
vation of L-currents is very slow (z253 slower than tslow
described here) in myotubes (Harasztosi et al., 1999).
Normal myotubes possess T-type Ca21 channels (Ad-
ams et al., 1990; Dirksen and Beam, 1995) that exhibit
a similar rate of activation as that associated with Afast.
However, our data strongly suggest that Afast does not
arise from T-type channels. First of all, the sum of two
exponentials is also required to ﬁt L-current activation
observed in normal myotubes that exhibit vanishingly
small (or undetectable) T-type Ca21 current (data not
shown). Moreover, the magnitude of Afast peaks at ap-
proximately 130 mV, z40 mV more depolarized than
the peak of the current–voltage relationship of T-type
Ca21 channels (Garcia and Beam, 1994). In addition,
Afast is potentiated by (2) Bay K 8644 (Figs. 4 and 5)
and exhibits a greater conductance for Ba21 than Ca21
(Fig. 6 B). These observations clearly contrast with the
classic proﬁle of T-type Ca21 channels (Hille, 1992),
and are most consistent with the notion that Afast origi-
nates from L-type Ca21 channels.
Dysgenic myotubes, which lack an intact gene for the
skeletal muscle DHPR, exhibit a rapidly activating,
DHP-sensitive L-current (Idys; Adams and Beam, 1989)
that may be attributable to the cardiac a1C subunit. It is
also likely that the channels that account for Idys make a
signiﬁcant contribution to the residual immobilization-
resistant intramembrane charge movement found in
dysgenic myotubes (Qdys; Adams et al., 1990). The fast
component of L-current activation (Afast) described in
this study resembles Idys in that both currents peak at
approximately 120 mV, activate rapidly (tact z 5 ms),
and are augmented two- to threefold by (2) Bay K
8466. However, several ﬁndings suggest that the fast
component of skeletal L-current activation is distinct
from Idys. For example, Idys is more strongly stimulated
by (2) Bay K 8644 than L-current in normal myotubes
(Adams and Beam, 1989; Strube et al., 1998). However,
the data in Fig. 5 shows that (2) Bay K 8644 stimulates
both kinetic components of L-current activation (Afast
and Aslow) to a roughly similar degree. In addition,
expression of RyR1 in dyspedic myotubes causes a
marked increase in Afast without altering the magnitude
of Qmax (Fig. 3), an observation clearly inconsistent
with Idys as the identity of Afast. Finally, substitution of
Ba21 for extracellular Ca21 doubles the size of Idys, but
only enhanced Afast in normal, and not dyspedic, myo-
tubes (Fig. 6, B and D). Thus, our data are inconsistent
with Idys as the identity of the fast component of skeletal
L-channel activation, but rather support the notion
that Afast represents an intrinsic gating property of the
skeletal L-channel.
It is uncertain whether the two components of
L-channel activation in mouse skeletal myotubes reﬂect
the gating of separate ion channels or two gating
modes of a single Ca21 channel protein. However, our
data support the latter possibility since RyR1 regulates
several properties of these two components in a quanti-477 Avila and Dirksen
tatively similar manner. For example, Afast and Aslow are
each reduced approximately sevenfold in the absence
of RyR1, resulting in a constant relative contribution of
fast and slow components to the total L-current in both
normal and dyspedic myotubes. Interestingly, RyR1 ex-
pression increased Afast to a value comparable with that
of normal myotubes and only partially restored Aslow, re-
sulting in a moderately signiﬁcant (P , 0.05) increase
in the relative contribution of Afast. In addition, both
tfast and tslow are approximately twofold faster in dys-
pedic myotubes, and expression of RyR1 in dyspedic
myotubes restores both tfast and tslow to values similar to
those of normal myotubes. Based on single channel re-
cordings (Dirksen and Beam, 1996) and gating current
measurements (Dirksen and Beam, 1999), slow skeletal
L-channel activation has been accounted for by a linear
reaction scheme in which the rate-limiting transition
exhibits an asymmetric voltage dependence. According
to this scheme, faster L-channel activation observed in
the absence of RyR1 (dyspedic myotubes) could arise
from an increase in the forward rate constant (“d” in
the model of Dirksen and Beam, 1996) governing this
rate-limiting transition. In this way, RyR1 may act like a
tether stabilizing one or more of the closed states tra-
versed during channel activation. According to this hy-
pothesis, single L-channels recorded from dyspedic my-
otubes would be anticipated to exhibit a briefer time to
ﬁrst opening after depolarization and possibly a de-
crease in channel closed times.
Distribution and Targeting of L-Channels in Dyspedic and 
RyR1-expressing Dyspedic Myotubes
Skeletal muscle dihydropyridine receptors and ryano-
dine receptors colocalize in clusters that are randomly
distributed in punctate foci throughout the muscle cell
(Flucher et al., 1993; Franzini-Armstrong and Jor-
gensen, 1994). These clusters occur at junctions be-
tween terminal SR and both the surface and transverse-
tubule (t-tubules) membranes and presumably repre-
sent functional sites of skeletal muscle EC coupling
(Franzini-Armstrong et al., 1991; Franzini-Armstrong
and Jorgensen, 1994). Within these junctions, SR Ca21
release channels are packed in highly ordered arrays.
Moreover, clusters of four evenly spaced membrane par-
ticles (tetrads), apparently representing DHPRs, are po-
sitioned in the sarcolemma such that each particle is lo-
cated immediately above each of the four RyR1 subunits
of the release channel homotetramere (Block et al.,
1988). In dyspedic myotubes, junctions containing large
clusters of DHPRs are present periodically throughout
the sarcolemma (though in a limited number; Takekura
et al., 1995). Thus, RyR1 proteins are not required for
the targeting of DHPRs to the junctional domains. How-
ever, the junctional clusters of DHPRs in dyspedic myo-
tubes are not organized into tetrads, indicating that
RyR1 proteins dictate the positioning of DHPRs into tet-
rads (Takekura and Franzini-Armstrong, 1999).
Our results, in which injection with RyR1 cDNA re-
stores both the ICa/Qmax (Fig. 2) and Gmax/Qmax (Table
I) ratios of dyspedic myotubes to values comparable
with those of normal myotubes, indicate that the vast
majority of dyspedic sarcolemmal L-channels are func-
tionally “recoupled” upon RyR1 expression. Thus, it is
possible that the expressed RyR1 proteins are efﬁ-
ciently targeted to the majority of junctions throughout
the injected dyspedic myotubes. However, Lorenzon et
al. (1999) demonstrated that the distribution of GFP-
tagged RyR1 proteins expressed in dyspedic myotubes
are restricted to the region surrounding the site of in-
jection. Since our experiments were performed on
morphologically compact myotubes and we have not
monitored RyR1 localization after nuclear injection,
the spatial restrictions of the expressed RyR1 proteins
in our experiments cannot be easily inferred. However,
it will be interesting to determine whether the periodic
distribution of DHPRs throughout the dyspedic sarco-
lemma are reorganized in such a way as to permit inter-
action with a restricted distribution of RyR1 proteins.
RyR1 Acts as an Allosteric Modulator of Skeletal
L-Channel Activity
The functional properties of voltage-dependent Ca21
channels are markedly inﬂuenced by direct interac-
tions with auxiliary Ca21 channel subunits and intracel-
lular signaling proteins. With regard to L-channels,
b-subunits augment peak Ca21 current by increasing
the number of channels in the surface membrane (Lac-
erda et al., 1991; Singer et al., 1991; Wei, et al., 1991),
increasing channel open probability (Neely et al., 1993;
Shistik et al., 1995), and facilitating channel pore open-
ing (Neely et al., 1993). In addition, b-subunits also ac-
celerate the kinetics of L-channel activation and inacti-
vation (Singer et al., 1991; Wei et al., 1991) and shift ac-
tivation to more hyperpolarized voltages (Neely et al.,
1993). In skeletal muscle, the b1-subunit accelerates
L-channel activation (Lacerda et al., 1991; Varadi et al.,
1991), augments total DHP binding (Lacerda et al.,
1991), and promotes the targeting of a1-subunits to the
plasma membrane (Strube et al., 1996; Beurg et al.,
1997). In addition, the b1a-subunit, and not the b2a-sub-
unit, restores both L-current and EC coupling in myo-
tubes derived from mice carrying a null mutation in
the b1 gene (Beurg et al., 1999). The a2-d-subunit gen-
erally acts to potentiate the effects of b subunits on
L-current amplitude and kinetics (Singer et al., 1991)
and both the a2-d- and b-subunits enhance DHP bind-
ing to L-channels (Singer et al., 1991).
Several important intracellular signaling molecules478 Impact of RyR1 on Skeletal L-Channels
are also known to interact and modify the functional
properties of voltage-dependent Ca21 channels. For ex-
ample, the properties of neuronal N- and P/Q-type
Ca21 channels are modulated by interaction with synap-
tic membrane proteins (e.g., syntaxin and the 25-kD
synaptosome-associated protein, SNAP25) that control
vesicle docking and membrane fusion during neu-
rotransmitter release (for review, see Catterall, 1999). G
protein b/g-subunits directly inhibit neuronal N-, P/Q-,
and R-type Ca21 channels by reducing current ampli-
tude, slowing channel activation, and shifting channel
activation to more depolarized potentials (for review,
see Dolphin, 1998). Additionally, Ca21-dependent inac-
tivation of cardiac L-channels has recently been sug-
gested to involve a constitutive interaction between
calmodulin and the Ca21-channel complex (Peterson et
al., 1999). The interaction of ryanodine receptors with
L-channels in skeletal muscle (Nakai et al., 1996) and
neurons (Chavis et al., 1996) causes an enhancement of
Ca21 ﬂux through these channels. Our results demon-
strate that the skeletal muscle ryanodine receptor also
modiﬁes other important channel properties, including
L-channel expression level, voltage dependence and ki-
netics of activation, modulation by DHPs, and the rela-
tive conductance to Ca21 and Ba21. These results sup-
port the notion that RyR1 is an important allosteric
modulator of the skeletal L-channel, analogous to that
of a conventional Ca21 channel accessory subunit.
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